Pax Lab Heats Up With $46.7 Million in Series C Funding To Expand and Introduce New Product Lines
Botanical vaporizer manufacturer Pax Labs, recently rounded up funding worth $46.7 million in Series C financing from investors such as Tao Capital, Sand Hill Angels, Fidelity Management & Research Company and Sivia Capital. The funding will be used for international expansion and the manufacturing of new product lines.